Mirum Pharmaceuticals, Inc. (MIRM)

Import this data to Google Sheets with:

=jivedata("MIRM","financials")

Full statements spill as a table. For one cell: =jivedata("MIRM","Revenue") or =jivedata("MIRM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Mirum Pharmaceuticals, Inc.

MIRM • CIK 0001759425

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-109,154	$-87,606	$-22,136	$-833,966
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-162,424	$-86,912	$-21,427	$-857,538
Income Tax Expense (Benefit)	$991	$1,030	$1,936	$2,669
Net Income (Loss) Attributable to Parent	$-163,415	$-87,942	$-23,363	$-860,207
Weighted Average Number of Shares Outstanding, Basic	40,885,124	47,522,594	50,198,304	62,013,146
Revenue from Contract with Customer, Excluding Assessed Tax	$186,374	$336,888	$521,312	$618,067
Research and Development Expense (Excluding Acquired in Process Cost)	$102,609	$140,630	$186,178	$282,505
Selling, General and Administrative Expense	$145,880	$202,221	$257,030	$313,837
Operating Expenses	$295,528	$424,494	$543,448	$1,452,033
Investment Income, Interest	$13,735	$13,792	$12,727	$13,923
InterestExpenseNonoperating	—	$14,311	$14,389	$13,438
Gain (Loss) on Extinguishment of Debt	$-49,076	$0	$0	$0
Other Nonoperating Income (Expense)	$-2,824	$1,213	$2,371	$-24,057
Share-based Payment Arrangement, Expense	$35,023	$48,444	$71,424	$125,202

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$286,326	$222,503	$296,683	$330,728
Short-term Investments	$0	$57,812	$86,644	$107,563
Restricted Cash and Cash Equivalents	$100,000	$425	$1,482	$1,734
Accounts Receivable, after Allowance for Credit Loss, Current	$67,968	$78,286	$123,330	$145,360
Long-term Investments	—	$12,526	$8,105	$123,030
Inventory, Net	$22,312	$22,403	$24,887	$25,769
Property, Plant and Equipment, Net	$706	$1,139	$1,862	$2,251
Prepaid Expense and Other Assets, Current	$10,935	$11,784	$18,140	$26,890
Operating Lease, Right-of-Use Asset	$1,284	$8,675	$8,741	$12,024
Assets, Current	$387,541	$392,788	$549,684	$636,310
Intangible Assets, Net (Excluding Goodwill)	$252,925	$249,819	$260,921	$247,388
Other Assets, Noncurrent	$4,165	$5,382	$12,018	$22,244
Assets	$646,621	$670,754	$842,813	$1,044,981
Operating Lease, Liability, Noncurrent	$617	$7,972	$7,516	$10,465
Convertible Notes Payable, Noncurrent	$306,421	$308,082	$309,797	$750,079
Other Liabilities, Noncurrent	$3,849	$2,509	$5,011	$10,917
Liabilities	$397,951	$445,114	$528,123	$1,055,403
Accounts Payable, Current	$7,416	$14,618	$9,614	$23,427
Liabilities, Current	$87,064	$126,551	$205,799	$222,788
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$5	$5	$5	$6
Additional Paid in Capital, Common Stock	$803,260	$870,189	$981,878	$1,515,172
Retained Earnings (Accumulated Deficit)	$-556,239	$-644,181	$-667,544	$-1,524,926
Accumulated Other Comprehensive Income (Loss), Net of Tax	$1,644	$-373	$351	$-674
Stockholders' Equity Attributable to Parent	$248,670	$225,640	$314,690	$-10,422
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	46,723,143	48,338,096	51,896,391	64,754,699
Restricted Cash Equivalents	$0	$425	$1,482	$1,734
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$286,326	$222,928	$298,165	$332,462
Inventory, Raw Materials and Supplies, Gross	$2,998	$3,030	$2,898	$2,613
Inventory, Work in Process, Gross	$9,873	$16,089	$18,473	$20,139
Inventory, Finished Goods, Gross	$9,441	$3,284	$3,516	$3,017
Finite-Lived Intangible Assets, Gross	$266,590	$286,590	$321,590	$321,590
Finite-Lived Intangible Assets, Accumulated Amortization	$13,665	$36,771	$60,669	$74,202
Amortization of Intangible Assets	$10,500	$23,100	$23,900	$13,500
Finite-Lived Intangible Asset, Expected Amortization, Year One	$21,545	$23,898	$26,958	$26,742
Finite-Lived Intangible Asset, Expected Amortization, Year Two	$21,545	$23,791	$26,742	$26,742
Finite-Lived Intangible Asset, Expected Amortization, Year Three	$21,436	$23,575	$26,742	$26,742
Finite-Lived Intangible Asset, Expected Amortization, Year Four	$21,221	$23,575	$26,742	$26,742
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	$145,957	$131,405	$126,995	$126,995
Employee-related Liabilities, Current	$20,939	$32,248	$47,276	$28,389
Accrued Royalties, Current	$6,716	$9,361	$16,208	$16,204
Accrued Professional Fees, Current	$7,941	$12,545	$17,292	$21,886
Operating Lease, Liability, Current	$1,104	$1,709	$2,139	$2,405
Interest Payable, Current	$2,108	$2,108	$2,108	$527
Accrued Liabilities, Current	$78,544	$110,224	$196,185	$196,185

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-163,415	$-87,942	$-23,363	$-860,207
Net Cash Provided by (Used in) Operating Activities	$-70,944	$10,325	$55,827	$-227,267
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-133	$-1,297	$3,222	$-2,704
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$158,323	$-63,398	$75,237	$103,860
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$286,326	$222,928	$298,165	$412,558
Share-based Payment Arrangement, Noncash Expense	$35,023	$48,444	$71,424	$103,928
Payments to Acquire Investments	$27,329	$89,026	$97,425	$227,974
Depreciation, Depletion and Amortization	$10,829	$23,629	$24,244	$25,946
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	$153,000	$19,894	$74,425	$91,667
Payments to Acquire Property, Plant, and Equipment	$109	$993	$954	$1,474
Amortization of Debt Issuance Costs and Discounts	$1,117	$1,661	$1,739	$1,991
Payments to Acquire Businesses, Net of Cash Acquired	$212,762	$0	$0	$0
Gain (Loss) on Extinguishment of Debt	$-49,076	$0	$0	$0
Payments to Acquire Intangible Assets	$20,000	$20,000	$0	$35,000
Net Cash Provided by (Used in) Investing Activities	$-107,200	$-90,125	$-23,954	$-172,781
Foreign Currency Transaction Gain (Loss), Unrealized	$-1,764	$1,231	$1,720	$-1,544
Other Noncash Income (Expense)	—	$795	$1,401	$1,304
Proceeds from Issuance of Private Placement	$202,204	$0	$0	$259,948
Proceeds from Issuance of Common Stock	$14,480	$0	$0	$0
Proceeds from Convertible Debt	$305,304	$0	$0	$0
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$10,470	$17,699	$40,142	$48,594
Payment of Financing and Stock Issuance Costs	$281	$0	$0	$0
Net Cash Provided by (Used in) Financing Activities	$336,600	$17,699	$40,142	$506,612
Operating Lease, Payments	$1,079	$1,274	$2,590	$3,126
Interest Paid, Excluding Capitalized Interest, Operating Activities	$6,817	$12,650	$12,650	$13,028
Income Taxes Paid, Net	—	$1,004	$2,157	$1,637
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$473	$9,633	$2,444	$5,243
Increase (Decrease) in Accounts Receivable	$43,974	$11,426	$48,055	$48,784
Increase (Decrease) in Prepaid Expense and Other Assets	$3,600	$849	$5,756	$6,356
Increase (Decrease) in Inventories	$4,393	$3,166	$8,448	$4,966
Increase (Decrease) in Other Operating Assets	$511	$1,498	$5,663	$14,952
IncreaseDecreaseInOperatingLeaseLiability	$-940	$-782	$-1,896	$-2,306

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("MIRM","financials")

Full statements spill as a table. For one cell: =jivedata("MIRM","Revenue") or =jivedata("MIRM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.